Theme · live manifest · live theme JSON
MedTech Short '25: Vaccine Makers
5 tickers · $334.92B total market cap
Group: MedTech Short
This short basket targets vaccine-focused companies facing demand erosion, policy deprioritization, and declining funding as the political and healthcare focus under Trump 2.0 shifts away from infectious disease and toward chronic disease management. With RFK Jr. leading HHS and public pandemic fatigue, the environment is deeply unfavorable for vaccine pipeline monetization, public-private contracts, and valuation premiums.
MedTech Short '25: Vaccine Makers tracks 5 publicly listed stocks in this theme: GILD, MRNA, NVAX, PCVX, PFE. See the constituent table for details.
Thesis update: 2025-04-14
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc.GILD | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 3.11% | -3.65% | -11.69% | -0.63% | $162.02B | 20.0000 |
Pfizer Inc.PFE | 05/05/2026 (BMO) | 05/05/2026 (BMO) | 0.45% | 0.87% | -3.39% | -1.68% | $146.25B | 20.0000 |
Moderna, Inc.MRNA | 05/01/2026 (BMO) | 05/01/2026 (BMO) | 5.29% | -1.24% | 8.79% | 0.77% | $18.14B | 20.0000 |
Vaxcyte, Inc.PCVX | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -2.20% | -7.48% | -4.83% | -5.24% | $7.04B | 20.0000 |
Novavax, Inc.NVAX | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -9.38% | 13.95% | -7.69% | -3.58% | $1.46B | 20.0000 |
| Average | -0.55% | 0.49% | -3.76% | -2.07% | $66.98B | 20.0000 | ||
| Median | 0.45% | -1.24% | -4.83% | -1.68% | $18.14B | 20.0000 | ||
| Std Dev | 5.08% | 7.28% | 6.89% | 2.13% | $71.54B | 0.0% | ||
| Min | -9.38% | -7.48% | -11.69% | -5.24% | $1.46B | 20.0000 | ||
| Max | 5.29% | 13.95% | 8.79% | 0.77% | $162.02B | 20.0000 | ||
| % Positive Tickers | 60.00% | 40.00% | 20.00% | 20.00% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.